Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery

Obesity Surgery

Volumn 22, Issue 1, 2012, Pages 131-139

  Pardina, Eva ^a   Ferrer, Roser ^b,e   Baena Fustegueras, Juan Antonio ^c   Rivero, Joaquín ^d   Lecube, Albert ^b,f   Fort, Jose Manuel ^b,e   Vargas, Víctor ^b,g   Catalán, Roberto ^b,e   Peinado Onsurbe, Julia ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Bariatric surgery; CRP; Gastric bypass; IL 6; Inflammation; Obesity; TNF

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; GHRELIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTRAABDOMINAL FAT; LIVER; MALE; METABOLIC PARAMETERS; MORBID OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STOMACH BYPASS; SUBCUTANEOUS FAT; TISSUE INJURY; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOSE TISSUE, WHITE; ADULT; BARIATRIC SURGERY; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIVER; MALE; MIDDLE AGED; OBESITY, MORBID; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS; YOUNG ADULT;

EID: 84857370660     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0546-3     Document Type: Article

References (31)

1. MB Pepys GM Hirschfield 2003 C-reactive protein: a critical update J Clin Invest 111 12 1805 12 12813013 1:CAS:528:DC%2BD3sXkvV2ktb0%3D (Pubitemid 38057722)
2. GM Hirschfield MB Pepys 2003 C-reactive protein and cardiovascular disease: new insights from an old molecule QJM 96 11 793 807 14566035 1:STN:280:DC%2BD3svovFCnsw%3D%3D (Pubitemid 37369294)
3. J Danesh R Collins P Appleby, et al. 1998 Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 18 1477 82 9600484 1:STN:280:DyaK1c3mtFWisw%3D%3D (Pubitemid 28228207)
4. J Danesh J Muir YK Wong, et al. 1999 Risk factors for coronary heart disease and acute-phase proteins. A population-based study Eur Heart J 20 13 954 9 10361047 1:STN:280:DyaK1M3ptVyhsQ%3D%3D (Pubitemid 29281442)
5. M Frohlich A Imhof G Berg, et al. 2000 Association between C-reactive protein and features of the metabolic syndrome: a population-based study Diabetes Care 23 12 1835 9 11128362 1:CAS:528:DC%2BD3cXovVGgsrs%3D
6. JC Chambers S Eda P Bassett, et al. 2001 C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites Circulation 104 2 145 50 11447077 1:CAS:528:DC%2BD3MXlvVKkt7g%3D (Pubitemid 32655829)
7. ES Ford 1999 Body mass index, diabetes, and C-reactive protein among U.S. adults Diabetes Care 22 12 1971 7 10587828 1:STN:280:DC%2BD3c%2FlsFWnsg%3D%3D (Pubitemid 30433974)
8. T McLaughlin F Abbasi C Lamendola, et al. 2002 Differentiation between obesity and insulin resistance in the association with C-reactive protein Circulation 106 23 2908 12 12460870 1:CAS:528:DC%2BD38XovVelt7o%3D (Pubitemid 35424740)
9. SJ Cleland N Sattar JR Petrie, et al. 2000 Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease Clin Sci (Lond) 98 5 531 5 1:CAS:528:DC%2BD3cXktVOkt74%3D (Pubitemid 30261001)
10. CM Eklund 2009 Proinflammatory cytokines in CRP baseline regulation Adv Clin Chem 48 111 36 19803417 1:CAS:528:DC%2BD1MXhs1Wis7bF
11. WK Lagrand CA Visser WT Hermens, et al. 1999 C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100 1 96 102 10393687 1:STN:280:DyaK1Mzit1CltA%3D%3D (Pubitemid 29297946)
12. SK Fried DA Bunkin AS Greenberg 1998 Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 83 3 847 50 9506738 1:CAS:528:DyaK1cXivFOgsrs%3D (Pubitemid 28496456)
13. B Enkhmaa K Shiwaku E Anuurad, et al. 2005 Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians Clin Chim Acta 352 1-2 105 13 15653104 1:CAS:528: DC%2BD2MXkvFanuw%3D%3D (Pubitemid 40093861)
14. Standardization of anthropometric measurements: the Airlie (VA) Consensus Conference. Champaign, Human Kinetics Publishers. 1988.
15. P Deurenberg JA Weststrate JC Seidell 1991 Body mass index as a measure of body fatness: age- and sex-specific prediction formulas Br J Nutr 65 2 105 14 2043597 1:STN:280:DyaK3M3lsFWmtw%3D%3D
16. E Bonora R Micciolo AA Ghiatas, et al. 1995 Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism 44 12 1617 25 8786733 1:CAS:528:DyaK28XhtVOisw%3D%3D (Pubitemid 26102603)
17. MA Martinez Olmos D Bellido Guerrero V Blay Cortés 2004 Métodos de valoración de la distribución de la grasa corporal en el paciente obeso Rev Esp Obes II 1 42 9
18. DR Matthews JP Hosker AS Rudenski, et al. 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 412 9 3899825 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
19. R Sabugal MQ Robert J Julve, et al. 1996 Hepatic regeneration induces changes in lipoprotein lipase activity in several tissues and its re-expression in the liver Biochem J 318 2 597 602 8809052 1:CAS:528:DyaK28XlvFSmu70%3D (Pubitemid 26305963)
20. R Anty S Bekri N Luciani, et al. 2006 The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH Am J Gastroenterol 101 8 1824 33 16790033 1:CAS:528:DC%2BD28Xpslahs7g%3D (Pubitemid 44166593)
21. N Ouchi S Kihara T Funahashi, et al. 2003 Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 5 671 4 12578865 1:CAS:528:DC%2BD3sXot12juw%3D%3D (Pubitemid 36222590)
22. A Khera DK McGuire SA Murphy, et al. 2005 Race and gender differences in C-reactive protein levels J Am Coll Cardiol 46 3 464 9 16053959 1:CAS:528:DC%2BD2MXmvVKnsro%3D (Pubitemid 41040287)
23. A Imhof M Frohlich H Loewel, et al. 2003 Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe Clin Chem 49 4 669 72 12651827 1:CAS:528:DC%2BD3sXisFelu7g%3D (Pubitemid 36379539)
24. N Rifai PM Ridker 2003 Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation Clin Chem 49 4 666 9 12651826 1:CAS:528:DC%2BD3sXisFelu7s%3D (Pubitemid 36379538)
25. A Badawi A Klip P Haddad, et al. 2010 Type 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional intervention Diabetes, Metab Syndr Obes: Targets Ther 3 173 186
26. PA Kern S Ranganathan CL Li, et al. 2001 Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 280 5 E745 51 11287357 1:CAS:528:DC%2BD3MXjsVahs7s%3D
27. S Muller S Martin W Koenig, et al. 2002 Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors Diabetologia 45 6 805 12 12107724 1:STN:280:DC%2BD38zmsV2nsg%3D%3D
28. JN Fain SW Bahouth AK Madan 2005 Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue Biochem Pharmacol 69 9 1315 24 15826602 1:CAS:528:DC%2BD2MXjtFyqsLo%3D
29. AH Clementi AM Gaudy N van Rooijen, et al. 2009 Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling Biochim Biophys Acta 1792 11 1062 72 19699298 1:CAS:528:DC%2BD1MXht1ylur3J
30. JP Despres I Lemieux A Pascot, et al. 2003 Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome Arterioscler Thromb Vasc Biol 23 4 702 3 12692010 1:CAS:528:DC%2BD3sXkvVWqt7k%3D (Pubitemid 36438087)
31. CA Curat V Wegner C Sengenes, et al. 2006 Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin Diabetologia 49 4 744 7 16496121 1:CAS:528:DC%2BD28XitF2jtrc%3D (Pubitemid 43357549)